Arthur Tzianabos, Director at Homology Medicines, Inc. (FIXX), sold 10,616 shares at $1.39 ($15K) on 2023-01-09, disclosed to the SEC on 2023-01-11.
Scheduled sale ($15k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| FIXX | SELL | 2024-02-15 | $7K | — | Filing → |
| FIXX | SELL | 2022-01-12 | $20K | — | Filing → |
| STOK | SELL | 2021-02-23 | $607K | — | Filing → |